Evaluation of long-term sequential changes in bone mass and strength following withdrawal of incadronate disodium (YM175) in ovariectomized rats

Journal of Orthopaedic Science

Volumn 6, Issue 2, 2001, Pages 167-176

  Miyakoshi, Naohisa ^a   Sato, Kozo ^a   Tamura, Yasuki ^a   Tsuchida, Tsunehisa ^a   Kudo, Takuya ^a   Kasukawa, Yuji ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bisphosphonate; Histomorphometry; Mechanical strength; Ovariectomy

Indexed keywords

INCADRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE STRENGTH; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; FEMALE; FEMUR; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OVARIECTOMY; RAT; TIBIA;

EID: 0035064456     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007760100066     Document Type: Article

References (30)

1. Response of cortical bone to antircsorptive agents and parathyroid hormone in aged ovariectomized rats
2. Diphosphonates and painful feet
3. Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-inducce osteopcnia in growing rat femurs
4. The long-term skeletal effects of EHDP in dogs
5. Effect of disodium dihydrogen (cycloheptylamino) methylene bisphosphonate monohydrate (YM175) on the bone formation and resorption in rats and dogs. Histological examination
6. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: Dynamic histomorphometry of changes in bone mass
7. Effects of clodronate on cortical and trabecular bone in ovariectomized rats on a low calcium diet
8. Effect of HEBP (1-hydroxyethylidene-1,1-bisphosphonic acid) on inflammation-mediated osteopenia in the rat
9. A quantitative histologic analysis of the growing long bone metaphysis
10. Effect of disodium ethane-1-hydroxy-1,1-diphosphonate on bone formation
11. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats
12. Effect of EHDP on fracture healing in dogs
13. 2 and risedronate administration on cancellous bone in older female rats
14. A histomorphometric study on effects of single and concurrent intermittent administration of human PTH (1-34) and bisphosphonate cimadronate on tibial metaphysis in ovariectomized rats
15. Ethane-1-hydroxy-1,1-diphosphonate (EHDP) effects on growth and modeling of the rat tibia
16. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction
17. Hyperostosis induced by the bisphosphonate (2-PEBP) in the oophorectomized rat
18. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats
19. Bone histomorphometry: Standardization of nomenclature, symbols, and units
20. Prevention of postmenopausal bone loss by tiludronate
21. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats
22. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats
23. Osteopetrosis: Current clinical considerations
24. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
25. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats
26. Effect of body weight on osteopenia in ovariectomized rats
27. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats
28. Long-term effects of ovariectomy and aging on the rat skeleton
29. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats
30. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats